Citadel Advisors - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$180,122
-48.6%
604,437
-71.5%
0.00%
Q2 2023$350,621
-82.9%
2,118,557
+0.9%
0.00%
Q1 2023$2,050,095
-7.3%
2,100,507
-1.2%
0.00%
Q4 2022$2,210,583
-9.0%
2,125,561
+0.6%
0.00%
-100.0%
Q3 2022$2,430,000
-37.7%
2,112,043
+1.3%
0.00%0.0%
Q2 2022$3,899,000
-40.8%
2,084,994
-4.0%
0.00%0.0%
Q1 2022$6,583,000
-18.9%
2,172,412
+1.2%
0.00%
-50.0%
Q4 2021$8,115,000
-36.7%
2,146,751
-13.4%
0.00%0.0%
Q3 2021$12,820,000
+48.7%
2,479,765
+10.2%
0.00%0.0%
Q2 2021$8,621,000
+185.3%
2,250,841
+91.4%
0.00%
+100.0%
Q1 2021$3,022,000
+7.3%
1,175,888
+4.4%
0.00%0.0%
Q4 2020$2,817,000
+18.2%
1,126,761
-2.2%
0.00%0.0%
Q3 2020$2,384,000
-33.7%
1,151,718
-0.8%
0.00%0.0%
Q2 2020$3,598,000
+30.5%
1,160,699
-4.0%
0.00%0.0%
Q1 2020$2,757,000
-35.6%
1,209,269
+2.3%
0.00%
-50.0%
Q4 2019$4,278,000
+872.3%
1,181,740
+816.3%
0.00%
Q3 2019$440,000
-41.3%
128,962
-19.2%
0.00%
Q2 2019$750,000
+62.7%
159,590
+16.1%
0.00%
Q1 2019$461,000
+3.4%
137,466
-18.1%
0.00%
Q4 2018$446,000
-58.9%
167,813
-13.3%
0.00%
Q3 2018$1,084,000
+190.6%
193,617
+162.7%
0.00%
Q2 2018$373,000
+0.3%
73,707
+35.1%
0.00%
Q1 2018$372,000
+383.1%
54,563
+432.2%
0.00%
Q4 2017$77,00010,2520.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders